Sp576
THE ROLE OF THE GASTRIC FUNCTION IN FI REGULATION
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
ABNORMAL GI MOTILITY IS A MAJOR FACTOR IN EXPLAINING SYMPTOMS IN PATIENTS WITH DGBI
A session focusing on recent advances in our understanding of the complex pathophysiology of disorders of gut-brain interaction (DGBI)…
PHARMACOGENETIC INTERACTIONS OF MEDICATIONS ADMINSTERED FOR WEIGHT LOSS IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
BACKGROUND: Sound evidence support the effectiveness of the transoral outlet reduction (TORe) with full-thickness endoscopic suturing (FTS) or argon plasma coagulation (APC) alone to address post-RYGB weight regain…
THE CLINICAL VALUE OF BIOMARKER-BASED APPROACHES FOR THE EVALUATION AND MANAGEMENT OF IRRITABLE BOWEL SYNDROME: PRICE VS. PRECISION
DDW attendees will have the opportunity to learn about recent developments in biomarker-discovery for FGID/DGBI and Neurogastroenterology…
MACHINE-LEARNING DRIVEN, FULL PHENOTYPE MODEL AND SURROGATE POLYGENIC RISK SCORE MODEL FOR APPETITE PREDICT RESPONSE TO GLP-1 RECEPTOR AGONIST IN PATIENTS WITH OBESITY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…